UNSPSC 51241137: Sodium propionate

This classification denotes an industrial aid with the molecular formula C3H5O2.Na.H2O, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier DK6Y9P42IN, chemically known as propionic acid, sodium salt but more generally known as sodium propionate, which bears U.S. NIH Compound Identifier 8724. European Medicines Agency schedules Sodium propionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15322MIG.

World Health Organization schedules sodium propionate in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary.

UNSPSC 51241137 Sodium propionate, a Commodity code, encompasses pharmaceutical and over-the-counter product procurement by state and local government entities through cooperative purchasing vehicles and direct acquisition. State agencies and multistate purchasing consortiums source sodium propionate—typically used as a food preservative and antimicrobial agent in pharmaceutical formulations and OTC products—as part of broader generic pharmaceutical and ingredient-supply contracts. The issuing bodies operating under this code include state procurement offices administering cooperative agreements and participating member jurisdictions across multiple states, leveraging consolidated purchasing to negotiate volume pricing and maintain compliance with federal manufacturing and supply-chain security standards.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted a Request for Proposal on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. The solicitation encompasses participation from Oregon and other member states and requires vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with awarded contracts effective July 1, 2026. Evaluation criteria weight price competitiveness at 75 percent, compliance with administrative data format and electronic data interchange capability at 10 percent combined, and certification of compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA) as mandatory qualifications. The contract term is two years for new responders with optional extensions at MMCAP's discretion, and vendors must maintain commercial general liability insurance of $5,000,000 per occurrence along with network security and professional liability coverage of $2,000,000 each.